# PAXIL CR Bioequivalence Study

> **NCT00749359** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 166 (actual)

## Conditions studied

- Depressive Disorder

## Interventions

- **DRUG:** Paxil CR

## Key facts

- **NCT ID:** NCT00749359
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07-07
- **Primary completion:** 2008-09-16
- **Final completion:** 2008-09-16
- **Target enrollment:** 166 (ACTUAL)
- **Last updated:** 2017-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00749359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00749359, "PAXIL CR Bioequivalence Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00749359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*